MB-110
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MB-110, covering 2017-04-05 to 2017-04-05. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, PK and Antiviral Activity of MB-110 in Hepatitis C Virus Infected Patients [Phase 1]